ライフサイエンスコーパス: pulmonary arterial pressure

1 tion of inspired oxygen, shunt fraction, and pulmonary arterial pressure.

2 xygenation without a significant decrease in pulmonary arterial pressure.

3 pulmonary capillary wedge pressure and mean pulmonary arterial pressure.

4 Mean pulmonary arterial pressure.

5 ally in the presence of chronic elevation of pulmonary arterial pressures.

6 ks, significant decreases were noted in mean pulmonary arterial pressure (-10%) and in pulmonary vasc

7 od flow [Qs] of 2.0 +/- 0.7) and normal mean pulmonary arterial pressure (13.4 +/- 3.1 mm Hg).

8 at pre-stage II evaluation, including higher pulmonary arterial pressures (15.4+/-3.0 versus 14.5+/-3

9 ressure (10+/-4 versus 6+/-3 mm Hg; P=0.02), pulmonary arterial pressure (22+/-8 versus 11+/-4 mm Hg;

10 received simvastatin from Day 5 to 35 (mean pulmonary arterial pressure = 27 +/- 3 mm Hg, RV/LV+S =

11 s and right ventricular workload by lowering pulmonary arterial pressure (29.6 +/- 1.3 vs. 24.6 +/- 1

12 ations included 79+/-9% (mean+/-SEM) rise in pulmonary arterial pressure, 30+/-7% decline in cardiac

13 improvements in hemodynamic variables (mean pulmonary arterial pressure: 40 +/- 12 mm Hg vs. 33 +/-

14 an-European study, 91 patients with PH (mean pulmonary arterial pressure 46+/-15 mm Hg) underwent cli

15 , rats that received vehicle had higher mean pulmonary arterial pressures (53 +/- 2 mm Hg) and right

16 PTT, FWHM, and TTP were associated with mean pulmonary arterial pressure and cardiac index.

17 ve pulmonary vasodilator, leading to reduced pulmonary arterial pressure and improved ventilation/per

18 via the suppression of the acute increase in pulmonary arterial pressure and improvement of right ven

19 nstrate that SB525334 significantly reverses pulmonary arterial pressure and inhibits right ventricul

20 Hypothermic CPB increased both mean pulmonary arterial pressure and left pulmonary vascular

21 Marked reductions in pulmonary arterial pressure and pulmonary vascular resis

22 sed, and there was a small reduction in mean pulmonary arterial pressure and pulmonary vascular resis

23 Their mean pulmonary arterial pressure and pulmonary vascular resis

24 hypoxemia with a pronounced increase in mean pulmonary arterial pressure and pulmonary vascular resis

25 mia but caused significant increases in mean pulmonary arterial pressure and pulmonary vascular resis

26 d results in an additive favorable effect on pulmonary arterial pressure and pulmonary vascular resis

27 1, and 0.3 mg x kg(-1) x h(-1)) reduced mean pulmonary arterial pressure and pulmonary vascular resis

28 mice was associated with a reduction in mean pulmonary arterial pressure and pulmonary vascular resis

29 ivity, and cGMP levels and partially restore pulmonary arterial pressure and pulmonary vascular resis

30 nitric-oxide synthase (eNOS) have increased pulmonary arterial pressure and pulmonary vascular resis

31 vector encoding the eNOS gene (AdCMVeNOS) on pulmonary arterial pressure and pulmonary vascular resis

32 We conclude that iron availability modifies pulmonary arterial pressure and pulmonary vascular respo

33 lumen and contribute to the elevation of the pulmonary arterial pressure and reduce local lung tissue

34 , and angio-obliteration leading to elevated pulmonary arterial pressure and resistance, right ventri

35 Endotoxin caused an increase in pulmonary arterial pressure and right ventricular volume

36 ne whether varying iron availability affects pulmonary arterial pressure and the pulmonary vascular r

37 HIMF increased pulmonary arterial pressure and vascular resistance more

38 rtension (PPH) is characterized by increased pulmonary arterial pressure and vascular resistance.

39 lth and disease, including associations with pulmonary arterial pressure, and adverse neurological se

40 ean arterial pressure (MAP), cardiac output, pulmonary arterial pressure, and calculated pulmonary an

41 surement of mean systemic arterial pressure, pulmonary arterial pressure, and cardiac output.

42 nts of Ex-PHT are male sex, resting systolic pulmonary arterial pressure, and exercise parameters of

43 ent for recipient age, body mass index, mean pulmonary arterial pressure, and pretransplant diagnosis

44 PAOP, mean pulmonary arterial pressure, and pulmonary capillary pre

45 In controls subjects, right atrial pressure, pulmonary arterial pressure, and pulmonary capillary wed

46 ignificant improvement in exercise capacity, pulmonary arterial pressure, and quality of life.

47 eases (<10 percent) in systemic arterial and pulmonary arterial pressures, and it had no effect on pu

48 t, oxygen delivery [DO2]), mean systemic and pulmonary arterial pressures, and the oxygenation index

49 lling pressure and the resultant increase in pulmonary arterial pressure are associated with disrupti

50 hypertrophy, restoring right ventricular and pulmonary arterial pressures, as well as the pulmonary v

51 ide animals showed a significant increase in pulmonary arterial pressure at 30 mins (47.5 +/- 2.4 and

52 ndary end points comprised cardiac index and pulmonary arterial pressure at rest and during exercise

53 oppler estimates and invasive measurement of pulmonary arterial pressure at rest and peak exercise we

54 ventilation, ventilation-perfusion matching, pulmonary arterial pressure, basal airway tone, and resp

55 id regurgitation velocity-time integral, and pulmonary arterial pressure between patients with and wi

56 Pulmonary ventilation and pulmonary arterial pressure both rise progressively duri

57 ean right atrial pressure by 12 +/- 3%, mean pulmonary arterial pressure by 13 +/- 2%, and pulmonary

58 g vasculature, dose-dependently reducing the pulmonary arterial pressure by as much as 9 mmHg with no

59 used significant decreases in total Hb, mean pulmonary arterial pressure, cardiac index and systemic

60 rch infusion was accompanied by increases of pulmonary arterial pressure, cardiac index, and blood ox

61 Heart rate, mean arterial pressure, pulmonary arterial pressure, central venous pressure, ka

62 chi(2), 28.8; P=0.003) and exercise systolic pulmonary arterial pressure (chi(2), 40.1; P=0.002) and

63 nals, echocardiographic measures of systolic pulmonary arterial pressure correlated reasonably well w

64 pressure of at least 10 mm Hg with the mean pulmonary arterial pressure decreasing to 40 mm Hg or be

65 Increased pulmonary arterial pressure did not affect arterial oxyg

66 ata exist regarding its accuracy to estimate pulmonary arterial pressure during exercise.

67 p had significantly higher mean systemic and pulmonary arterial pressures during resuscitation in com

68 DCLHb raised systemic and pulmonary arterial pressures from baseline values of 83

69 sociated with HSA, which raised systemic and pulmonary arterial pressures from baseline values of 86

70 Pulmonary arterial pressure >/=15 mm Hg was 90% specific

71 zation to confirm the diagnosis of PAH (mean pulmonary arterial pressure >/=25 mm Hg and pulmonary ca

72 namics consistent with POPH (defined as mean pulmonary arterial pressure >25 mm Hg and pulmonary vasc

73 with secondary pulmonary hypertension (rest pulmonary arterial pressure >25 mm Hg).

74 ng PHT and Ex-PHT were defined as a systolic pulmonary arterial pressure >50 and >60 mm Hg, respectiv

75 By 2 hrs, pulmonary arterial pressure had decreased but was still

76 on and, with the exception of an increase in pulmonary arterial pressure, had no adverse effects on h

77 ard ratio, 1.09; P=0.027), exercise systolic pulmonary arterial pressure (hazard ratio, 1.03; P<0.001

78 , 5.2; 95% CI, 1.8-14.8; P = 0.002) and mean pulmonary arterial pressure (hazard ratio, 1.04; 95% CI,

79 Mild idiopathic pulmonary arterial pressure impairs LV diastolic complia

80 oxic challenge produced similar increases in pulmonary arterial pressure in both groups.

81 Reduced pulmonary arterial pressure in MGCD0103-treated animals

82 tion of AdRSVeNOS attenuated the increase in pulmonary arterial pressure in mice exposed to the fibro

83 y baroreceptors is obtained at physiological pulmonary arterial pressures in intact animals.

84 Pulmonary arterial pressure increased after hemoglobin i

85 Mean pulmonary arterial pressure increased relative to baseli

86 The increase in pulmonary arterial pressure induced in shunt lambs was g

87 Acute increases in PaO2, decreases in mean pulmonary arterial pressure, intensity of mechanical ven

88 O(2) (pO(2))] elicits signaling to regulate pulmonary arterial pressure is incompletely understood.

89 tested the hypotheses that (1) elevated mean pulmonary arterial pressure is the most important hemody

90 s model, we found that the acute increase in pulmonary arterial pressure leading to right ventricle f

91 e and noninvasive), central venous pressure, pulmonary arterial pressure, left and right atrial press

92 arge body mass index, preoperative increased pulmonary arterial pressure, low stroke volume index, hy

93 ts with tricuspid regurgitation grade >2 and pulmonary arterial pressure <50 mm Hg.

94 ry arteries, leads to sustained elevation of pulmonary arterial pressure (mean >25 mm Hg at rest or >

95 Mean pulmonary arterial pressure, mean left atrial pressure,

96 The compound reduced pulmonary arterial pressure more dramatically than tadal

97 death, mean systemic pressure (mSP) and mean pulmonary arterial pressure (mPA) emerged as the most im

98 ons between biventricular MPRI and both mean pulmonary arterial pressure (mPAP) (RV MPRI: rho = -0.59

99 ptolide-treated rats demonstrated lower mean pulmonary arterial pressure (mPAP) than vehicle-treated

100 ary hypertension (PH) is diagnosed by a mean pulmonary arterial pressure (mPAP) value of at least 25

101 heal instillation of liposomal fasudil, mean pulmonary arterial pressure (MPAP) was reduced by 37.6+/

102 L-NAME resulted in a larger increase in mean pulmonary arterial pressure (MPAP) when compared with sa

103 used a marked and sustained decrease in mean pulmonary arterial pressure (MPAP), it also decreased me

104 e, pulmonary artery occlusion pressure, mean pulmonary arterial pressure (MPAP), systemic vascular re

105 able to produce precise measurements of mean pulmonary arterial pressure (mPAP).

106 (odds ratio, 4.3; P=0.002), resting systolic pulmonary arterial pressure (odds ratio, 1.16; P=0.002),

107 (odds ratio 1.60, 95% CI 1.09 to 2.32), mean pulmonary arterial pressure of > or = 20 mm Hg (odds rat

108 progressively to 50 mL/kg/min, maintaining a pulmonary arterial pressure of < 25 mm Hg and a left atr

109 e is generally defined as a decrease in mean pulmonary arterial pressure of at least 10 mm Hg with th

110 acterized by a progressive elevation in mean pulmonary arterial pressure, often leading to right vent

111 There was no significant difference in pulmonary arterial pressure or systemic arterial pressur

112 ), with no changes in right atrial pressure, pulmonary arterial pressure, or pulmonary resistance.

113 , increased Pao(2) (p <.001), and lower mean pulmonary arterial pressure (p <.001).

114 is found ventricle classification (P=0.001), pulmonary arterial pressure (P</=0.001) annulus area (P=

115 most closely associated with increased mean pulmonary arterial pressure (P=0.016).

116 They also had increased pulmonary arterial pressures (P< .05) with elevated leve

117 ransposase showed a significant reduction in pulmonary arterial pressure (PABP, 31.67+/-6.03 mmHg, P<

118 variables were mean arterial pressure, mean pulmonary arterial pressure, PAOP, pulmonary capillary p

119 During normoxic conditions, mean pulmonary arterial pressure (PAP) and pulmonary to syste

120 Values of SPP were plotted against mean pulmonary arterial pressure (PAP) and sigmoid functions

121 RBCs from hypoxemic patients with elevated pulmonary arterial pressure (PAP) exhibit a similar FeNO

122 Physiological increases in pulmonary arterial pressure (PAP) induced significant in

123 luded mean right atrial pressure (RAP), mean pulmonary arterial pressure (PAP), cardiac index, transp

124 The increase in pulmonary arterial pressure (PAP), PVR, RVM, and pulmona

125 of the sixty patients with COPD had PH (mean pulmonary arterial pressure [PAPm] >/= 25 mm Hg).

126 nous flow can occur when PA exceeds both the pulmonary arterial pressure (Ppa) and pulmonary venous p

127 , rats that received vehicle had higher mean pulmonary arterial pressures (Ppa = 41 +/- 3 mm Hg) (p <

128 ements (mean+/-SD, 8.3+/-2.8 per subject) of pulmonary arterial pressure, pulmonary arterial wedge pr

129 Cardiac output, pulmonary arterial pressure, pulmonary artery occlusion

130 Sildenafil reduced exercise pulmonary arterial pressure, pulmonary vascular resistan

131 amic variables (cardiac output, systemic and pulmonary arterial pressures, pulmonary artery occlusion

132 with wedge pressure (r = 0.93, P < .001) and pulmonary arterial pressure (r = 0.93, P < .002).

133 Pulmonary arterial pressure (r=0.66), annulus area (r=0.

134 groups 2 to 4, hemodynamic functions (except pulmonary arterial pressure) recovered, yet neither tota

135 usion resulted in a greater increase in mean pulmonary arterial pressure relative to cardiac output i

136 alues, and 6%, 16%, 23%, and 23% in the mean pulmonary arterial pressure, respectively.

137 f statin therapy in the improvement of 6MWD, pulmonary arterial pressure, right atrial pressure, card

138 These variables included mean pulmonary arterial pressure, right ventricular total pow

139 With exercise, the mean pulmonary arterial pressure rose from 36+/-12 to 52+/-10

140 The liposome-induced rises of pulmonary arterial pressure showed close quantitative an

141 ood was allowed to drain into a reservoir as pulmonary arterial pressure started to rise after veratr

142 Pulmonary capillary wedge pressure, pulmonary arterial pressure, stroke volume, and cardiac

143 Sildenafil reduced resting pulmonary arterial pressure, systemic vascular resistanc

144 An increase in pulmonary arterial pressure that is not due to coexisten

145 intravenously administered to increase mean pulmonary arterial pressure to 35 mm Hg.

146 pulmonary capillary wedge pressure and mean pulmonary arterial pressure to volume loading with rapid

147 In patients with grade A TR signals, mean pulmonary arterial pressure-to-workload ratio at a thres

148 H based on QRS-gated DPD demonstrated higher pulmonary arterial pressures versus isolated postcapilla

149 Peak pulmonary arterial pressure was higher after resuscitati

150 Pulmonary arterial pressure was increased during sepsis

151 Mean pulmonary arterial pressure was significantly higher aft

152 An increase in pulmonary arterial pressure was the only observed hemody

153 Mean pulmonary arterial pressure was unchanged.

154 le pressures designed to simulate the normal pulmonary arterial pressure waveform.

155 ate, mean transmitral gradient, and systolic pulmonary arterial pressure were assessed at different s

156 Aortic blood flow, Pao(2), and pulmonary arterial pressure were measured 4 wks later.

157 nnular plane systolic excursion and systolic pulmonary arterial pressure were measured at rest and du

158 for 10 minutes), and LAP, systemic flow, and pulmonary arterial pressure were measured in both fixed

159 PVR and mean pulmonary arterial pressure were not significant predict

160 Mean pulmonary arterial pressures were comparable (46+/-4 and

161 , in turn, may play a key role in increasing pulmonary arterial pressure, which is involved in the de

162 ikewise, none of the other indices including pulmonary arterial pressure (WMD: -0.97 mmHg, 95%CI: -4.